尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Jayne David R.W.. Insider active across 1 company, notably Aurinia Pharmaceuticals Inc.. Cumulatively, 6 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €117k. Activity tracked since 18 May 2022. The latest transaction was filed on 21 November 2024 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Jayne David R.W. is a declarant and Director of Aurinia Pharmaceuticals Inc. (XNAS). There are 6 filings in total, and across the sampled recent filings from 2022-07-11 to 2024-11-25, the reported buys are 0 EUR and the reported sells are 117459 EUR, with the modal transaction nature shown as Attribution.